T-cell intracellular signaling machinery

The T-cell intracellular signaling machinery is a complex network of proteins that transduces signals from the T-cell receptor (TCR) and co-receptors to the nucleus to initiate immune responses (Courtney et al., 2018, PubMed: 29126530). This machinery includes proximal signaling molecules like Lck and ZAP-70, which initiate a cascade involving adaptor proteins such as LAT and SLP-76, and second messengers like calcium (Smith-Garvin et al., 2009, PubMed: 19413331). These pathways ultimately activate key transcription factors, including NFAT, NF-κB, and AP-1, which drive the expression of genes necessary for T-cell proliferation and cytokine production. Dysregulation of these signaling pathways is a hallmark of autoimmune diseases, such as rheumatoid arthritis and psoriasis, as well as various T-cell malignancies (Brownlie & Zamoyska, 2013, PubMed: 23470321). Therapeutic intervention often targets specific enzymes within this machinery; for example, calcineurin inhibitors like Cyclosporine and JAK inhibitors like Tofacitinib are used to suppress immune activity in transplantation and chronic inflammation (Flanagan et al., 2010, PubMed: 20414293). While effective, modulating these central pathways requires careful management due to the inherent risks of systemic immunosuppression and off-target toxicities.

Other names

T-cell receptor signaling pathwayTCR signaling cascadeT-cell activation pathwayT-cell signal transduction network

Inhibition of specific intracellular signaling nodes such as calcineurin, mTOR, Janus kinases (JAK), or Src-family kinases (Lck) to prevent T-cell activation, proliferation, and effector cytokine production.